Cancer Detection and Treatment Leads To The Spread of The Disease Itself

WIKI - CancerDave Mihalovic, Prevent Disease
Waking Times

Cancer is a deadly disease, but it is also a wonderful revenue generation tool for multi-national conglomerates. Not only pharmaceutical companies, but hospitals, oncologists, cancer specialists, diagnostic facilities, and many other distinct entities that comprise a 125 billion dollar cancer industry. Cancer awareness propaganda and detection revolves around funneling patients through various levels of diagnoses and treatment to maximize profits at the expense of human health.

Cancer is disease of convenience, especially for those who wish to tell us they want a cure. They don’t. Why would they? Why would an industry that generates 125 billion dollars suddenly want that to go away. The medical establishment has retreated from the truth. What began as an investigation into the root causes of a complex set of idiopathic diseases quickly degenerated into a single-minded focus…money.

Money is really the only reason chemotherapy is still used today. Not because it’s effective, decreases morbidity, mortality or diminishes any specific cancer rates. In fact, it does the opposite. Chemotherapy boosts cancer growth and long-term mortality rates. Most chemotherapy patients either die or are plagued with illness within 10-15 years after treatment. It destroys their immune system, increases neuro-cognitive decline, disrupts endocrine functioning and causes organ and metabolic toxicities. Patients basically live in a permanent state of disease until their death.

Screening for cancer is “disease mongering” at its worst. By casting a large net with early detection schemes, people are roped into laboratory tests, imaging, doctors’ office visits, biopsies, surgeries, radiation treatments, pharmaceuticals, chemotherapies, and hospitalizations. Disease mongering turns people into patients, and few will benefit.


  • Early Cancer Detection Is A Complete Lie

    “Early detection” is a misnomer. At the time of diagnosis, a solid tumor developing in the breast, colon, lung, or prostate has grown to one centimeter (1/2 inch) in size and contains 1 billion cells. The average time for this growth to reach a detectable size is 10 years. Cancer destined to spread to other vital organs has already done so. Fortunately, most tumors found during screening are destined to be non-troublesome and are likely to continue on their non-lethal (benign) course.

    Cancer begins as one misguided cell dividing at its own free will, irrespective of its neighbors’ welfare. The average doubling time is every 100 days (3.5 months). Approximately 30 doublings must occur for a cancer to reach a detectable size. Basic math proves this to be, “late detection.” Cancer cells spread early in the disease via the venous system to vital organs (where many metastatic cells will divide at a similar rate to the original tumor cells).

    Researchers have understood the natural growing history of solid cancers, like those found in the breasts, colon, lung, and prostate, for more than a half-century. Consider this 1977 statement delivered at the, “Conference on Breast Cancer: A Report to the Profession” sponsored by the White House, the National Cancer Institute, and the American Cancer Society: “If the time required for a tumor to double its diameter during a known period of time is taken as a measure of growth rate, one can calculate by extrapolation that two-thirds of the duration of a breast cancer remains undetectable by the patient or physician. Long before a breast carcinoma can be detected by present technology, metastatic spread may occur and does in most cases.”

    cancer_industry-12

    Explosion of Secondary Cancers Via Cancer Treatment

    Not only does cancer treatment increase metastatic spread, but it takes the immune system with it causing an explosion of secondary cancers. In fact, as the mainstream started treating just about every cancer patient with chemo and radiation, the number of Americans getting second cancers started exploding. The rate has doubled since just the 1970s — and one-in-five cancer cases in America is now a second cancer. More patients are dying from associated symptoms of chemotherapy and radiation than the cancer itself.

    Chemotherapy drugs (especially alkylating agents) are known to cause other cancers including leukemia many of these drugs fall into this class. Alkylating agents directly damage DNA of all cells. These agents are not phase-specific; in other words, they work in all phases of the cell cycle. Because these drugs damage DNA, they can cause long-term damage to the bone marrow and consequently affect long-term immunity. With these drugs, the risk for a second cancer develops slowly over time but their diagnosis is inevitable. Studies have shown that the risk begins to rise about two years after treatment, is highest about five to 10 years after treatment. It’s the reason most chemotherapy patients die 10-15 years after treatment.

    Radiation therapy can also increase the risk of developing cancer in most people. The types of cancers linked to radiation therapy are vast, but primarily consist of leukemia and sarcomas. These cases typically develop a few years after radiation exposure with the peak of risk being about five to nine years after exposure. Again, most patients that pursue radiation therapy develop secondary cancers related to treatment and not as a consequence of the original cancer. Radiation-induced cancers have exploded in the past two decades ever since radiation has proliferated as a treatment, usually secondary to chemotherapy.

    Some other cancer risks are tied to radiation therapy, as well. Solid tumors can develop at or near the site of the radiation exposure even 10 or more years after the radiation therapy. These risks seem to be greatest in certain areas of the body, such as the breast and the thyroid. In some of these cases, your age at the time of radiation treatment plays a role. For example, younger breast cancer patients are more likely to develop a second cancer from radiation therapy than older breast cancer patients.

    The problem has gotten so serious that chief medical officers are being forced to warn the public about the risks of chemotherapy advising doctors to be conservative in how they use it.

    “Improved Survival” and “Increased Detection” Does Not Save Lives

    Few correctly recognize that only reduced mortality (a longer life) in a randomized trial constitutes evidence of the benefit of screening.

    The first fatal error is in believing that “improved survival” is beneficial. The length of survival is measured from the time of diagnosis until death. By finding disease earlier with screening programs the diagnosis is made earlier, but the day of death remains the same. The patient does not live longer (no improvement in mortality), but he or she is made aware of his or her illness for more years by finding it earlier. Without argument this awareness leads to enhanced profits for many medical industries.

    The second error in thinking arises from the belief that finding more cancers benefits patients. Most cancers found by screening are over-diagnosed: they are non-troublesome and are non-lethal, and would have been of no importance if never discovered.

    The reason a 5-year relative survival rate is the standard used to assess mortality rates is due to most cancer patients going downhill after this period. It’s exceptionally bad for business and the cancer industry knows it. They could never show the public the true 97% statistical failure rate in treating long-term metastatic cancers. If they did publish the long-term statistics for all cancers administered cytotoxic chemotherapy, that is 10+ years and produced the objective data on rigorous evaluations including the cost-effectiveness, impact on the immune system, quality of life, morbidity and mortality, it would be very clear to the world that chemotherapy makes little to no contribution to cancer survival at all. No such study has ever been conducted by independent investigators in the history of chemotherapy. The only studies available come from industry funded institutions and scientists and none of them have ever inclusively quantified the above variables.

    In the early stages of tumors (the dubious ones) the recovery rates are extremely high, while in the following stages — that is, where they certainly are tumors — the rates are barely above zero. The reason for the discrepancy is the qualification of the data and how a patient is assessed in terms of recovery. Immune reconstitution and tolerance, organ and metabolic toxicities, endocrine challenges, functional outcomes, quality of life, and neurocognitive outcomes are NEVER inclusively assessed in any clinical study discussing the long-term survival and recovery rates of cancer patients. The damage to these systems slowly develops after chemotherapy, however if often does not begin to manifest throughout the body until several months or even years have passed. It takes time, but within a 3-5 year period, most chemotherapy patients begin to have many more symptoms of disease than they every had before their diagnosis, due to and as a direct result of cytotoxic drug intervention.

    Adjuvant chemotherapy is often given to patients who might not really need it at all. Oncologists do not consider the whole spectrum of chemotherapy risks versus benefits and thus compromise quality of life for every patient they treat. A study in the Annals of Oncology is one of few which assessed the different potential long-term adverse events associated with adjuvant chemotherapy in cancer, with a particular focus on long-term cardiac toxicity, secondary leukemia, cognitive function, and neurotoxicity. The authors stated that the adverse events are frequently overshadowed by the well-demonstrated clinical efficacy and/or reassuring short-term safety profiles of the different chemotherapy regimens commonly used today.

    Another study in the American Society of Clinical Oncologydetermined whether long-term survivors of metastatic testicular cancer have an increased risk of cardiovascular morbidity more than 10 years after chemotherapy. They observed a significantly increased risk for occurrence of cardiac events accompanied by a persisting unfavorable cardiovascular risk profile likely due to chemotherapeutic agents.

    A 12-year meta-analysis published in the Journal of Clinical Oncologyobserved adults who had developed cancer and treated with chemotherapy. The 12-year study looked at adults who had developed cancer as an adult. 97% of the time, chemotherapy did not work in regressing the metastatic cancers.

    Cancers discovered only after death, say at an autopsy, obviously never threatened the patient’s life. The person has died of something else first, say, heart disease or old age, long before the cancer surfaced. Early detection tests uncover “pseudo” and dormant cancers. For every one person whose life is “saved by early detection,” 10 to 50 people are over-diagnosed with cancer. Meddling physicians have turned healthy people into casualties of cancer.

    90% of Patients Who Receive Chemotherapy Suffer Fatal Effects

    The National Confidential Enquiry into Patient Outcome and Death (NCEPOD) found that more than four in ten patients who received chemotherapy towards the end of life suffered potentially fatal effects from the drugs, and treatment was “inappropriate” in nearly a fifth of cases.

    Globally, almost 90% of patients who are administered chemotherapy die within 15 years of treatment either from secondary cancers, or a compromised immunity as a direct consequence of the treatment. Chemotherapy and radiation combined are the leading cause of secondary cancer worldwide.

    There has been a 68% increase in the use of chemotherapy drugs since 2003 and despite the massive increase in the incidence of cancer since then; the risk factors (according to the cancer industry) for primary and secondary cancers are still related to tobacco, alcohol, occupational exposures and genetic determinants. Cancer treatment or diagnostics is never mentioned as a cause of any primary or secondary cancers.

    Cancer is a leading cause of disease worldwide and if recent trends in major cancers are seen globally in the future, the burden of cancer will increase to 22 million new cases each year by 2030. This represents an increase of 75% compared with 2008

    More than half of all cancer patients suffer significant treatment-related toxicity. Treatment can also result in life-threatening infections or patients may simply die of their cancer.

    When asked about how to improve a patient’s response and outcome, Nelson replied “alternatively, it may be possible to use smaller, less toxic doses of therapy.”

    But small doses of poison are still poison.

    The bottom line is that chemotherapy destroys virtually all cells and systems before getting to the actual cancer. This means your central nervous system, organ systems and your immune system (to name just a few) are all compromised even years after the treatment has subsided. Forget about cancer killing you because chemotherapy will do a much better job in the long term.

    Chemotherapy causes healthy brain cells to die off long after treatment has ended and may be one of the underlying biological causes of the cognitive side effects — or “chemo brain” — that many cancer patients experience.

    Conventional cancer treatment is a massive and expensive fraud–a non-treatment that sickens and kills more people than it ever “cures.” It can never cure anything because it poisons the body which only causes more disease in the future.

    The question of whether or not cancer treatment really extends life can probably no longer be answered effectively by even the cancer industry itself. In clinical studies the manufacturers always compare their new drugs with older cellular poisons. There are no control groups that are given no treatment at all.

    Today, the most effective method of being cancer-free is to prevent it by using dietary strategies, high-nutrient foods, lifestyle and behavior modification.

    What are 5 Ways You Can Decrease Yours Odds of Getting Cancer?

    1. Detoxify your body (decrease cellular toxicity and increase oxygenation to cells)Eliminating environmental toxins from your diet (by eating organically grown foods and avoiding chlorinated/fluoridated water) and your surroundings (by using non-toxic, natural cleansers, cosmetics, furniture, building materials, and clothing) will go a long way toward eliminating cancer from your life. There are a variety of ways to detox your body via water fasts, juice feasts (where you drink only fruit and vegetable juices for a set number of days), and full-on detoxification programs.

    2. Exercise (increase blood flow)One cause of poor oxygenation is poor circulation. If cells are oxygen starved they are more likely to become cancerous. So, when one exercises and increases circulation, oxygenation improves and more nutrients will be carried into the cells.

    3. Proper eating habits (to create proper building blocks for cell walls)Diet is a crucial weapon in your cancer-fighting arsenal. You should eat organic whole foods whenever possible to reduce toxins. Increase your intake of essential fatty acids from organic cold-pressed flax oil or fish oil.

    Cancer thrives on sugar and refined grains. Cut them out as much as possible, and don’t use artificial sweeteners as they are not healthy. Recently, new healthy sweeteners such as stevia, xylitol, and Laknato have become widely available.

    4. Eat mainly alkaline foodsFoods that are acidic to the body consist of: meats, poultry, fish, dairy products, eggs, junk food, soda, alcohol, coffee, grains, and cereals. These foods you want to minimize in your diet. Alkaline foods, on the other hand, consist mainly of fruits and vegetables. A good percentage to aim for is 75% alkaline foods and 25% acidic foods. This may be challenging in the beginning because many people’s diets are the exact opposite. Once this becomes a bit more natural, a general guideline to shoot for is: 45% cooked fruits and vegetables, 30% RAW fruits and vegetables and 25% grains, nuts, seeds, meat, fish, or poultry.

    There have, in addition, been research that shows the benefits of a 100% raw food diet in the treatment of cancer. The Gerson institute in San Diego, California provides an alternative to treating cancer. The Gerson Therapy is a natural treatment that activates the body’s extraordinary ability to heal itself through an organic, vegetarian diet, raw juices, coffee enemas and natural supplements. Over the past 60 years thousands of people have been cured of ‘incurable diseases’ including: cancer, diabetes, heart disease, arthritis, and auto-immune disorders. Talk about food as medicine!

    5. Support your body’s ability to use oxygen to make energyA nutrient vital in the production of energy in a cell is CoEnzymeQ10. If a cell doesn’t have CoQ10, it can’t produce energy. Also, research shows that (high-quality) Omega-6 oils increase oxygen transfer into cells.

    Remember, the more ways you attack cancer, the better your chances are of beating it. The best alternative cancer clinics in the world use multiple supplements and holistic treatments. They don’t do just one thing. If possible, do the same yourself.

    About the Author

    Dave Mihalovic is a Naturopathic Doctor who specializes in vaccine research, cancer prevention and a natural approach to treatment.

    Sources:
    mwt.net
    nlm.nih.gov
    drmcdougall.com
    cancerdecisions.com
    preventdisease.com
    douglassreport.com
    hsionline.com
    ncbi.nlm.nih.gov

    Like Waking Times on Facebook. Follow Waking Times on Twitter.

    ~~ Help Waking Times to raise the vibration by sharing this article with friends and family…


    No, thanks!

    -->